Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study

There are limited data on cardiovascular efficacy and safety of type 2 diabetes therapies in Japan, where treatments are characterized by lower metformin use and higher dipeptidyl peptidase‐4 inhibitor (DPP4i) use versus other countries. We investigated the cardiovascular outcomes in Japanese patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohsaka, Shun, Takeda, Masayoshi, Bodegård, Johan, Thuresson, Marcus, Kosiborod, Mikhail, Yajima, Toshitaka, Wittbrodt, Eric, Fenici, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779275/
https://www.ncbi.nlm.nih.gov/pubmed/32530554
http://dx.doi.org/10.1111/jdi.13321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779275/
https://www.ncbi.nlm.nih.gov/pubmed/32530554
http://dx.doi.org/10.1111/jdi.13321

Ejemplares similares